DETROIT – Enhancing the brain's inherent ability to rebuild itself after a stroke with molecularcomponents of stem cells holds enormous promise for treating the leading cause of long-termdisability in adults.
Michael Chopp, Ph.D., Scientific Director of the Henry Ford Neuroscience Institute, will presentthis approach to treating neurological diseases Thursday, Feb. 13, at the American HeartAssociation's International Stroke Conference in San Diego.